ArticleAntimicrobial agents and chemotherapy2022

Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica.

Monica M Kangussu-Marcolino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.